IBLHL Stock Overview
Engages in marketing, selling, and distribution of healthcare and pharmaceutical products in Pakistan. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
IBL HealthCare Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | PK₨40.32 |
| 52 Week High | PK₨49.00 |
| 52 Week Low | PK₨25.80 |
| Beta | 1.03 |
| 1 Month Change | -0.40% |
| 3 Month Change | 28.29% |
| 1 Year Change | 14.22% |
| 3 Year Change | -23.96% |
| 5 Year Change | -16.19% |
| Change since IPO | 617.85% |
Recent News & Updates
Recent updates
Shareholder Returns
| IBLHL | PK Healthcare | PK Market | |
|---|---|---|---|
| 7D | -6.7% | -1.4% | -2.5% |
| 1Y | 14.2% | -3.1% | 63.7% |
Return vs Industry: IBLHL exceeded the PK Healthcare industry which returned -3.1% over the past year.
Return vs Market: IBLHL underperformed the PK Market which returned 63.7% over the past year.
Price Volatility
| IBLHL volatility | |
|---|---|
| IBLHL Average Weekly Movement | 9.0% |
| Healthcare Industry Average Movement | 5.2% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in PK Market | 10.2% |
| 10% least volatile stocks in PK Market | 4.8% |
Stable Share Price: IBLHL's share price has been volatile over the past 3 months compared to the PK market.
Volatility Over Time: IBLHL's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of PK stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 292 | Muhammad Ghiyasuddin | www.iblhc.com |
IBL HealthCare Limited engages in marketing, selling, and distribution of healthcare and pharmaceutical products in Pakistan. The company offers toddlers, baby cereals, infant formulas, medical and lifestyle nutrition, and speciality nutrition products; hygiene and safety products; consumer health products; and vision care and pharma products. It also provides renal care products, such as hollow fiber dialyzer, tubing sets for hemodialysis, double lumen catheter kits, and disposable AV fistula needles; critical care and anesthesia products, such as meditech connectors, circuits, filters, anesthesia masks, and oxygen therapy products; surgical and examination gloves; pharmaceuticals; blood transfusion sets and blood bags; IV administration products; and surgical tape, urine collection bags with T-connector, oxygen face; and nebulizer masks, nasal oxygen cannula, infant feeding tubes, and suction catheter.
IBL HealthCare Limited Fundamentals Summary
| IBLHL fundamental statistics | |
|---|---|
| Market cap | PK₨3.45b |
| Earnings (TTM) | -PK₨12.49m |
| Revenue (TTM) | PK₨3.62b |
1.0x
P/S Ratio-276.5x
P/E RatioIs IBLHL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IBLHL income statement (TTM) | |
|---|---|
| Revenue | PK₨3.62b |
| Cost of Revenue | PK₨2.69b |
| Gross Profit | PK₨935.84m |
| Other Expenses | PK₨948.33m |
| Earnings | -PK₨12.49m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.15 |
| Gross Margin | 25.84% |
| Net Profit Margin | -0.34% |
| Debt/Equity Ratio | 19.2% |
How did IBLHL perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/25 21:45 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
IBL HealthCare Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|